Clinical Chemistry, Malmö
1061 – 1070 of 1293
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Analytical considerations for free protein S assays in protein S deficiency
(
- Contribution to journal › Article
-
Mark
A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor
(
- Contribution to journal › Article
-
Mark
Ny in vitro-analys prövad: Blödningstid fortfarande bästa metod för test av den primära hemostasen
(
- Contribution to journal › Article
- 2000
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
(
- Contribution to journal › Article
-
Mark
Increased presence of cells containing transforming growth factor alpha (TGF-alpha) in ulcerative colitis, both during active inflammation and in remission
(
- Contribution to journal › Article
-
Mark
The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation
(
- Contribution to journal › Article
-
Mark
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
(
- Contribution to journal › Article
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
(
- Contribution to journal › Article
-
Mark
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
(
- Contribution to journal › Article
-
Mark
Human glandular kallikrein 2 (hK2) in prostate cancer: Clinical and Methodological studies
2000)(
- Thesis › Doctoral thesis (compilation)